We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance in Immunohistochemical Testing

By HospiMedica staff writers
Posted on 31 Jan 2002
A collaboration to develop and market reagent kits and antibodies used in immunohistochemical (IHC) testing worldwide has been announced by ChromaVision Medical Systems, Inc. More...
(San Juan Capistrano, CA, USA) and Richard-Allan Scientific Company (Kalamazoo, MI, USA).

Richard-Allan will manufacture antibodies and reagents for ChromaVision to market along with its Automated Cellular Imaging System (ACIS), which combines color-based imaging technology with automated microscopy. The combination of specialized reagent kits and the ACIS digital microscope system will provide laboratory and pathology customers with an integrated laboratory testing tool to address the growing need for standardized, quantifiable IHC testing information. Reagent kits that support tests most frequently performed by customers on the ACIS system are expected to be available in the near future, followed by a full suite of kits that support all tests performed using the system.

"Richard-Allan Scientific is the worldwide leader in reagent, consumable, and equipment sales to the anatomical pathology market, while the ChromaVision ACIS has emerged as the most widely used imaging system in clinical practice,” said Carl W. Apfelbach, president and COO of ChromaVision. "This alliance provides a unique sales growth opportunity for both companies.”




Related Links:
Richard-Allan
ChromaVision

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Clinical Informatics Platform
CLARION™
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.